These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
347 related items for PubMed ID: 383331
1. Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG. Convit J, Aranzazu N, Pinardi M, Ulrich M. Clin Exp Immunol; 1979 May; 36(2):214-20. PubMed ID: 383331 [Abstract] [Full Text] [Related]
2. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results. Gormus BJ, Baskin GB, Xu K, Ratterree MS, Mack PA, Bohm RP, Meyers WM, Walsh GP. Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891 [Abstract] [Full Text] [Related]
3. Comparison of various preparations of Mycobacterium leprae and other mycobacteria by lymphocyte stimulation. Bjune G. Int J Lepr Other Mycobact Dis; 1978 Sep; 46(3-4):386-93. PubMed ID: 83309 [Abstract] [Full Text] [Related]
4. Prospective immunological follow-up in household contacts of Mexican leprosy patients. Amezcua ME, Escobar-Gutiérrez A, Barba-Rubio J, Cázares JV, Mayén E, Chávez-Núñez M, Peña RC, Rodríguez R, Pastén S. Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):651-9. PubMed ID: 2280115 [Abstract] [Full Text] [Related]
5. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae. Gupte MD, Anantharaman DS, De Britto RL, Vallishayee RS, Nagaraju B, Kannan S, Sengupta U. Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275 [Abstract] [Full Text] [Related]
7. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial). Majumder V, Mukerjee A, Hajra SK, Saha B, Saha K. Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110 [Abstract] [Full Text] [Related]
17. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy. Rada E, Ulrich M, Aranzazu N, Santaella C, Gallinoto M, Centeno M, Rodriguez V, Convit J. Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953 [Abstract] [Full Text] [Related]
18. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules. Bapat CV, Modak MS, DeSouza NG, Chulawalla RG. Lepr India; 1977 Oct; 49(4):472-84. PubMed ID: 342823 [Abstract] [Full Text] [Related]
19. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta. Chaudhury S, Hajra SK, Mukerjee A, Saha B, Majumdar V, Chattapadhya D, Saha K. Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754 [Abstract] [Full Text] [Related]
20. Comparison in leprosy patients of Fernandex and Mitsuda reactions using human and armadillo antigens. A double-blind study. Millar JW, Gannon C, Chan CS. Int J Lepr Other Mycobact Dis; 1975 Mar; 43(3):226-33. PubMed ID: 1240871 [Abstract] [Full Text] [Related] Page: [Next] [New Search]